ORTEXORTEX News
Tracking AAK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AA
Trader NoteAAK

AAK Insiders Buy the Dip as Borrow Loosens

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 7 Nov 2026, 21:21

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

AAK AB enters November with two board members buying shares in the open market just days apart, a signal worth noting given the stock's sharp post-earnings drop and the subsequent 3% weekly recovery.

The insider activity is the clearest angle this week. Sten Estrup Nielsen bought 5,000 shares on November 2 at SEK 176.47, and Niall Patrick Sands picked up 2,000 shares on October 28 at SEK 176.20. Both are board-level purchases, not compensation grants, made in the week immediately after the October 23 earnings release, when AAK fell 6.5% on the day and extended losses to roughly 7% over the following five sessions. Buying into that kind of post-results weakness, at prices well below the current close of SEK 182.60, reads as a show of confidence rather than routine housekeeping. Sands had also bought 2,362 shares in July at SEK 211.40, taking his average cost well above the current price.

The lending market is relaxed, which removes one source of pressure on the stock. Borrow availability has loosened meaningfully over the past fortnight, climbing from below 80% in mid-October to 116.5% now, meaning there are more shares available to lend than are currently borrowed. Cost to borrow has drifted back to around 1%, close to its lowest level of the past six weeks after a brief spike toward 2.3% on October 30. The ORTEX short score, at 79.6, remains elevated in absolute terms but has eased from 81.1 on October 23, the day of the earnings release. The combined picture is one of shorts who are present but not adding aggressively.

Analysts remain constructive despite the earnings stumble. The consensus sits at buy, with five buy ratings against one hold, and a mean price target of SEK 231.38, implying roughly 27% upside from current levels. The analyst data is current to late October, so it reflects the post-results picture. EV/EBITDA has drifted up slightly over the past month to 8.7x, while the PE has edged higher to 12.6x as the share price lagged earnings revisions. The dividend score ranks in the 96th percentile, consistent with AAK's track record of steady dividend growth, most recently an extraordinary dividend proposed in February 2026. EPS momentum over both 30 and 90 days is weak, in the 14th and 25th percentile respectively, reflecting the market's reaction to the latest print.

Ownership is dominated by Schörling & Partners, which controls 30.5% of shares and has not moved its stake. Alecta, the Swedish pension fund, trimmed 200,000 shares to bring its holding to around 4.9%, the most recent institutional move in the data. The next earnings event is scheduled for February 5, 2027, which gives the insider purchases roughly three months to play out before the company reports again.

The key question heading into Q4 is whether the margin improvement flagged in September's note can be sustained, or whether October's earnings miss represents a more durable reset of expectations at a stock that still trades at a meaningful premium to its recent lows.

Stocks in this article

See the live data behind this article on ORTEX.

Open AAK on ORTEX →

How this article was generated

Generated
7 Nov 2026, 21:21
Data as of
7 Nov 2026, 21:21
Prompt version
v1.0
Data sources
Cost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.